Two SPARK-BIH funded teams network with investors and the life science industry at the international JPM BIO Partnering Event.
We wish you SPARKling holidays and a good start in a successful new year!
Can the neurological consequences of chemotherapy be prevented?
SPARK-BIH and BMBF-funded PREPARE study investigates protective effect of lithium in breast cancer patients.
In October 2022, Dr. Tanja Rosenmund, head of SPARK-BIH, together with her team welcomed fourteen new projects to the SPARK-BIH program. She and her team are excited to support the new SPARKees to translate their innovation from bench to bedside.
We are happy to share the new High-Tech Gründerfonds podcast about SPARK-BIH
VDI/VDE Innovation Interview with EpiBlock founder and SPARK alumni Prof. Heilbronn
Newly founded company of SPARK team MyoPax receives 1.3 million Euro loan
Thank you for participating in our 2022 SPARK-BIH Call and NeuroCure/SPARK Call sessions
We are a mentoring network aiming to accelerate the translation of academic inventions into clinically relevant drugs, diagnostics and medical devices.
Validate your research findings and translate them into therapies, products or services to help patients.
Share your expertise with our SPARKees and participate in our program as SPARK advisor.
SPARK-BIH is a member of the SPARK Global network